Literature DB >> 28381920

Promising Drugs in Clinical Development To Treat Advanced Colorectal Cancer.

Chris Fellner.   

Abstract

We present immunotherapies, biosimilars, and molecular-targeted agents in late-stage development for patients with advanced colorectal cancer.

Entities:  

Year:  2017        PMID： 28381920      PMCID： PMC5358685     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  9 in total

Review 1.  Cancer stem cells: the promise and the potential.

Authors:  Jaffer A Ajani; Shumei Song; Howard S Hochster; Ira B Steinberg
Journal:  Semin Oncol       Date:  2015-01-21       Impact factor: 4.929

Review 2.  Cancer stem cells: mirage or reality?

Authors:  Piyush B Gupta; Christine L Chaffer; Robert A Weinberg
Journal:  Nat Med       Date:  2009-09-04       Impact factor: 53.440

Review 3.  The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.

Authors:  M Hoyle; L Crathorne; J Peters; T Jones-Hughes; C Cooper; M Napier; P Tappenden; C Hyde
Journal:  Health Technol Assess       Date:  2013-04       Impact factor: 4.014

4.  STAT3 expression, molecular features, inflammation patterns, and prognosis in a database of 724 colorectal cancers.

Authors:  Teppei Morikawa; Yoshifumi Baba; Mai Yamauchi; Aya Kuchiba; Katsuhiko Nosho; Kaori Shima; Noriko Tanaka; Curtis Huttenhower; David A Frank; Charles S Fuchs; Shuji Ogino
Journal:  Clin Cancer Res       Date:  2011-02-10       Impact factor: 12.531

5.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

Review 6.  Role of mast cells in colorectal cancer development, the jury is still out.

Authors:  J Heijmans; N V Büller; V Muncan; G R van den Brink
Journal:  Biochim Biophys Acta       Date:  2010-12-09

Review 7.  Palliation of colorectal cancer.

Authors:  Nir Wasserberg; Howard S Kaufman
Journal:  Surg Oncol       Date:  2007-10-29       Impact factor: 3.279

8.  Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.

Authors:  Patrice Dubreuil; Sébastien Letard; Marco Ciufolini; Laurent Gros; Martine Humbert; Nathalie Castéran; Laurence Borge; Bérengère Hajem; Anne Lermet; Wolfgang Sippl; Edwige Voisset; Michel Arock; Christian Auclair; Phillip S Leventhal; Colin D Mansfield; Alain Moussy; Olivier Hermine
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

Review 9.  Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.

Authors:  Jie Yuan; Fei Zhang; Ruifang Niu
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379
  9 in total
  3 in total

1.  Immunostimulatory TLR7 agonist-nanoparticles together with checkpoint blockade for effective cancer immunotherapy.

Authors:  Ching-Hsin Huang; Natalie Mendez; Oscar Hernandez Echeagaray; Joi Weeks; James Wang; Shiyin Yao; Sarah L Blair; Natalie Gude; William C Trogler; Dennis A Carson; Tomoko Hayashi; Andrew C Kummel
Journal:  Adv Ther (Weinh)       Date:  2020-03-16

2.  Effects of Radiotherapy in Combination With Irinotecan and 17-AAG on Bcl-2 and Caspase 3 Gene Expression in Colorectal Cancer Cells.

Authors:  Mahnaz Ebrahimpour; Mahshid Mohammadian; Bagher Pourheydar; Zhino Moradi; Zhaleh Behrouzkia
Journal:  J Lasers Med Sci       Date:  2022-02-28

Review 3.  Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries.

Authors:  Ricardo Eccard da Silva; Angélica Amorim Amato; Débora Dornelas Belchior Costa Andrade; Alessandra Vanessa Leite E Silva; Marta Rodrigues de Carvalho; Maria Rita Carvalho Garbi Novaes
Journal:  J Oncol       Date:  2018-07-02       Impact factor: 4.375
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.